{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:27:50Z","timestamp":1792686470760,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T00:00:00Z","timestamp":1706227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biology and Craniofacial Research"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jobcr.2024.01.014","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T16:07:23Z","timestamp":1706803643000},"page":"126-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8879-310X","authenticated-orcid":false,"given":"George","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Diecidue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jobcr.2024.01.014_bib1","first-page":"920","article-title":"Kademani D AAOS position paper on MRONJ-2022 update","volume":"80","author":"Ruggerio","year":"2022","journal-title":"J Oceanogr Mar Sci"},{"issue":"9","key":"10.1016\/j.jobcr.2024.01.014_bib2","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.4158\/EP.14.9.1150","article-title":"Bisphosphonate-associated osteomyelitis of the jaw: guidelines for practicing clinicians","volume":"14","author":"Wimalawansa","year":"2008","journal-title":"Endocr Pract"},{"issue":"11","key":"10.1016\/j.jobcr.2024.01.014_bib3","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"issue":"5","key":"10.1016\/j.jobcr.2024.01.014_bib4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3390\/antiox10050680","article-title":"Various therapeutic methods for the treatment of medication-related osteonecrosis of the jaw (MRONJ) and their limitations: a narrative review on new molecular and cellular therapeutic Approaches","volume":"10","author":"On","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.jobcr.2024.01.014_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s00784-015-1706-y","article-title":"Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts","author":"Zafar","year":"2016","journal-title":"Clin Oral Invest"},{"key":"10.1016\/j.jobcr.2024.01.014_bib6","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1359\/jbmr.060118","article-title":"Inhibition of protein prenylation by bisphosphonates causes sustained activation of rac, Cdc42, and rho GTPases","volume":"21","author":"Dunford","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jobcr.2024.01.014_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00784-014-1320-4","article-title":"Walter C Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation","volume":"19","author":"Hagelaurer","year":"2015","journal-title":"Clin Oral Invest"},{"issue":"4","key":"10.1016\/j.jobcr.2024.01.014_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1177\/0022034514564187","article-title":"Ozeki, okabe K mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition","volume":"94","author":"Nagaoka","year":"2015","journal-title":"J Dent Res"},{"issue":"3","key":"10.1016\/j.jobcr.2024.01.014_bib9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.oraloncology.2010.12.003","article-title":"Geranylgeraniol-a new potential therapeutic approach to BRONJ","volume":"47","author":"Zeibart","year":"2011","journal-title":"Oral Oncol"},{"issue":"10","key":"10.1016\/j.jobcr.2024.01.014_bib10","first-page":"2564","article-title":"Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts","volume":"69","author":"Cozin","year":"2011","journal-title":"JOMS"},{"key":"10.1016\/j.jobcr.2024.01.014_bib11","article-title":"Cheng J geranylgeraniol restores zoledronic acid induced efferocytosis inhibition in bisphosphonate related osteonecrosis of the jaw","volume":"9","author":"Chen","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.jobcr.2024.01.014_bib12","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4351327","article-title":"Geranylgeraniol as a mevalonate pathway activator in the rescue of bone cells treated with zoledronic acid: an in vitro study","author":"Fliefel","year":"2019","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.jobcr.2024.01.014_bib13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jcms.2017.11.007","article-title":"In vivo effects of geranylgeraniol on the development of bisphosphonate-related osteonecrosis of the jaws","volume":"46","author":"Koneski","year":"2018","journal-title":"J Cranio-Maxillofacial Surg"},{"issue":"2","key":"10.1016\/j.jobcr.2024.01.014_bib14","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2006.04.007","article-title":"Calcium phosphate cements as bone drug delivery systems: a review","volume":"113","author":"Ginebra","year":"2006","journal-title":"J Contr Release"},{"issue":"6","key":"10.1016\/j.jobcr.2024.01.014_bib15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jps.2600840614","article-title":"A novel skeletal drug delivery system using self setting calcium phosphate cement","volume":"84","author":"Otsuka","year":"1995","journal-title":"J Pharmaceut Sci"},{"key":"10.1016\/j.jobcr.2024.01.014_bib16","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.bone.2015.08.012","article-title":"Animal Model for medication related osteonecrosis of the jaw with precedent metabolic bone disease","volume":"81","author":"Kim","year":"2015","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.jobcr.2024.01.014_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1111\/odi.12368","article-title":"An osteonecrosis model induced by oral bisphosphonate in ovariectomised rats","volume":"21","author":"Tanaka","year":"2015","journal-title":"Oral Dis"},{"issue":"4","key":"10.1016\/j.jobcr.2024.01.014_bib18","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/adj.12648","article-title":"Spontaneous medication related osteonecrosis of the jaw; two case reports and a systemic review","volume":"63","author":"Khominsky","year":"2018","journal-title":"Australian Dental J"},{"issue":"2","key":"10.1016\/j.jobcr.2024.01.014_bib19","first-page":"55","article-title":"Spontaneous MRONJ: bimodal treatment approach","volume":"70","author":"DeBenedictus","year":"2022","journal-title":"Gen Dent"},{"issue":"1","key":"10.1016\/j.jobcr.2024.01.014_bib20","volume":"9","author":"Manley","year":"2023","journal-title":"Schlieve T Spontaneous MRONJ in 23yo Oral and Maxillofacial Surg Cases"},{"key":"10.1016\/j.jobcr.2024.01.014_bib21","article-title":"Preclinical models of medication-related osteonecrosis of the jaw (MRONJ)","volume":"153","author":"Aguirre","year":"2021","journal-title":"Bone"},{"issue":"4","key":"10.1016\/j.jobcr.2024.01.014_bib22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1258\/0023677041958864","article-title":"Diurnal variation and age related changes of bone turnover markers in female Gottingen minipigs","volume":"38","author":"Tsutsumi","year":"2004","journal-title":"Lab Anim"}],"container-title":["Journal of Oral Biology and Craniofacial Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426824000228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426824000228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:29:53Z","timestamp":1761946193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212426824000228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2212426824000228"],"URL":"https:\/\/doi.org\/10.1016\/j.jobcr.2024.01.014","relation":{},"ISSN":["2212-4268"],"issn-type":[{"value":"2212-4268","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Geranylgeraniol (GGOH), incorporated into a bone cement pellet promotes osteoclast function and healing in a model of medication-related osteonecrosis of the jaw","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biology and Craniofacial Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jobcr.2024.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Craniofacial Research Foundation.","name":"copyright","label":"Copyright"}]}}